- Home
- CCTG vs GOVX Comparison
CCTG vs GOVX Comparison
Compare CCTG & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCTG
- GOVX
- Stock Information
- Founded
- CCTG 1993
- GOVX 2001
- Country
- CCTG Hong Kong
- GOVX United States
- Employees
- CCTG N/A
- GOVX N/A
- Industry
- CCTG
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- CCTG
- GOVX Health Care
- Exchange
- CCTG Nasdaq
- GOVX Nasdaq
- Market Cap
- CCTG 14.9M
- GOVX 15.5M
- IPO Year
- CCTG 2024
- GOVX N/A
- Fundamental
- Price
- CCTG $1.06
- GOVX $0.95
- Analyst Decision
- CCTG
- GOVX Strong Buy
- Analyst Count
- CCTG 0
- GOVX 5
- Target Price
- CCTG N/A
- GOVX $12.40
- AVG Volume (30 Days)
- CCTG 5.9K
- GOVX 1.5M
- Earning Date
- CCTG 08-23-2025
- GOVX 08-05-2025
- Dividend Yield
- CCTG N/A
- GOVX N/A
- EPS Growth
- CCTG N/A
- GOVX N/A
- EPS
- CCTG N/A
- GOVX N/A
- Revenue
- CCTG $16,463,490.00
- GOVX $5,591,576.00
- Revenue This Year
- CCTG N/A
- GOVX N/A
- Revenue Next Year
- CCTG N/A
- GOVX N/A
- P/E Ratio
- CCTG N/A
- GOVX N/A
- Revenue Growth
- CCTG 3.27
- GOVX N/A
- 52 Week Low
- CCTG $0.99
- GOVX $0.73
- 52 Week High
- CCTG $3.17
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- CCTG 39.49
- GOVX 46.22
- Support Level
- CCTG $1.05
- GOVX $0.85
- Resistance Level
- CCTG $1.12
- GOVX $1.39
- Average True Range (ATR)
- CCTG 0.04
- GOVX 0.15
- MACD
- CCTG 0.01
- GOVX -0.02
- Stochastic Oscillator
- CCTG 46.67
- GOVX 18.52
About CCTG CCSC Technology International Holdings Limited
CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas and Asia.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.